Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tachosil for Prevention of Hemorrhage After LEEP
NCT02629510Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Jan 2015
- Primary completion
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tachosil in cervical intraepithelial neoplasia (CIN), Cervical Cancer (CC), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
tachosil
03
Conditions
cervical intraepithelial neoplasia (CIN)Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02629510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629510.